Live News EQUITY L impact May 29, 2026, 12:30 PM UTC

Outlook Therapeutics Files 424B5

Outlook Therapeutics submits regulatory filing with the SEC. The filing provides updated information about the company.

SQUAWKNEWS Updated May 29, 2026, 12:32 PM UTC

Filed: 2026-05-29 AccNo: 0001104659-26-067917 Size: 484 KB